资源描述：
《胸痹通胶囊治疗pci术后再发心绞痛的疗效观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、提要目的：本论文主要研究胸痹通胶囊治疗PCI术后再发心绞痛的疗效观察。方法：临床研究中，将60例PCI术后再发心绞痛的患者纳入观察病例，并随机分为两组，两组患者均给与拜阿司匹灵、舒降之、波利维、鲁南欣康口服药物。治疗组在常规西药治疗基础上加服胸痹通胶囊（由潍坊市中医医院制剂中心生产），一次4粒，一日3次。伴有高血压、糖尿病患者给予相应的对症支持治疗。治疗4周后，对入组患者进行临床症状、心电图改变的观察，并检测实验室指标，进行治疗前后的对比，并通过相应的统计学对结果做进一步的分析。结果：1.在PCI术后再发心绞痛的缓解症状
2、和改善心电图方面，两组均有显著的疗效，治疗组的疗效要优于对照组。2.在改善中医症状方面，通过中医症候积分疗效评价，治疗组明显优于对照组。3.在血脂总胆固醇、甘油三酯及低密度脂蛋白检测方面，治疗后两组均有下降，并治疗组下降更明显。结论：通过临床观察，及各种指标检测，胸痹通胶囊是临床上治疗PCI术后再发心绞痛的一个安全、疗效确切的中药复方制剂，并因中药的毒副作用小及整体调治的特点，其应用前景广阔，优越性无法比拟，为中医药治疗PCI术后心绞痛提供新的思路和方法，同时也进一步完善胸痹通胶囊的临床应用范围。关键词冠心病心绞痛；PC
3、I术后再发心绞痛；胸痹通胶囊；中医药治疗XiongbitongcapsuleintreatmentofanginapectorisafterPCIobservationSpeciality:InternalMedicineofTCMAuthor：WangWenTutor：ProfessorTangKeqingAbstractObjective:ThispapermainlystudiesofxiongbitongcapsuleinthetreatmentofanginapectorisafterPCIoperationo
4、bservation.Methods:Inclinicalstudies,afterPCIinpatientswithanginapectoris60examplerandomlydividedintotwogroups,60intothecase,andtwogroupsofpatientsweregiventheoraldrugs.ofaspirin,simvastatin,Polivy,andlunanxinkang(manufacturedbyWeifangtraditionalChineseMedicineHo
5、spital),4capsules,3timesaday.Supportforrelativeaccompaniedbyhighbloodpressure,diabetestreatment.After4weeks,watchbeforeandafterclinicalsymptomsandSt-tchangesofECG,laboratorytestindex,andforstatisticalanalysis.Results:1.thetwogroupstoimprovesymptomreliefandelectro
6、cardiogramofanginahaveasignificanteffect,efficacyofthetreatmentgroupthanthecontrolgroup.2.thetwogroupsintermsofimprovedsymptomsoftraditionalChineseMedicine,treatmentsignificantlybetterthancontrolgroups.3.treatmentofthelattertwogroupstotalcholesterolandlowdensityl
7、ipoproteinlipidshaddropped,bloodrheology,andtherapygroupsfellevenmoreobvious.Conclusions:Throughtheclinicalobservation,XiongbitongcapsuleisthesafeandeffectivetraditionalChinesemedicinecompoundpreparationinthetreatmentofanginapectorisafterPCI,andduetosideeffectssm
8、allandtheoveralltreatmentoftraditionalChinesemedicine,hasbroadprospectsinthetreatmentofcoronaryheartdiseaseandotherdrugsincomparablesuperiority.Andprovidenewid
